Cervical cancer device wins One to Watch award
A new device for diagnosing cervical cancer has won its creator a One to Watch award from Enterprise Ireland.

The analyser — based on Raman spectroscopy and an algorithm developed at the Dublin Institute of Technology (DIT) — can detect cervical pre-cancer in Pap smears, a process currently carried out by skilled cytologists.
DIT’s Dr Fiona Lyng, who received the award in Dublin yesterday, is developing the analyser with colleagues at the Radiation and Environmental Science Centre and collaborators at the Coombe Women and Infants University Hospital.
Raman spectroscopy is a way of studying molecular structures using laser light, by examining how the photons in the beam interact with the molecules.
The technique can quickly generate a biochemical fingerprint of a sample without damaging it and is sensitive to subtle molecular changes, allowing variations corresponding to the onset of disease to be detected.
Lyng’s system can analyse and classify both cervical tissue and cervical smear samples with high sensitivity and specificity by comparing them with a pre-defined sample database.
The researchers say that the analyser could be used alongside the current histopathology and cytology methods to improve cervical cancer screening and diagnosis.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Breaking the 15MW Barrier with Next-Gen Wind Turbines
Hi Martin, I don´t have any detailed parameters for the 15MW design other than my reading of the comment in the report ´aerodynamic loads at blade-tip...